Cornerstone Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$232K	Sell	300 -10	-3%	-$7.66K	0.01%	641
2025 Q4	$239K	Buy	+310	New	+$211K	0.01%	611
2025 Q1	–	Sell	-310	Closed	-$221K	–	614
2024 Q4	$221K	Buy	310 +10	+3%	+$8.39K	0.01%	539
2024 Q3	$315K	Sell	300 -17	-5%	-$18.9K	0.02%	449
2024 Q2	$333K	Buy	317 +17	+6%	+$16.5K	0.03%	416
2024 Q1	$289K	Hold	300	–	–	0.02%	433
2023 Q4	$263K	Sell	300 -3	-1%	-$2.47K	0.02%	436
2023 Q3	$249K	Buy	303 +3	+1%	+$2.36K	0.02%	456
2023 Q2	$216K	Sell	300 -90	-23%	-$69.4K	0.02%	474
2023 Q1	$320K	Buy	+390	New	+$294K	0.03%	363
2022 Q3	$322K	Hold	468	–	–	0.04%	334
2022 Q2	$277K	Buy	468 +78	+20%	+$50.7K	0.03%	365
2022 Q1	$272K	Sell	390 -14	-3%	-$8.86K	0.03%	383
2021 Q4	$254K	Buy	+404	New	+$248K	0.02%	435
2018 Q4	–	Sell	-43,199	Closed	-$92K	–	962
2018 Q3	$92K	Sell	43,199 -60,738	-58%	-$23.1M	﹤0.01%	1270
2018 Q2	$296K	Buy	+103,937	New	+$32.5M	﹤0.01%	1205